KOPRAN:NSE Kopran Limited

INR 258.60 11.25 4.548211
Icon

Kopran Limited (KOPRAN:NSE) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | NSE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

INR 258.60

+11.25 (+4.55)%

INR 12.61B

0.45M

N/A

N/A

Icon

KOPRAN:NSE

Kopran Limited (INR)
COMMON STOCK | NSE
INR 258.60
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

INR 12.61B

N/A

INR 258.60

Kopran Limited (KOPRAN:NSE) Stock Forecast

N/A

Based on the Kopran Limited stock forecast from 0 analysts, the average analyst target price for Kopran Limited is not available over the next 12 months. Kopran Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Kopran Limited is Slightly Bearish, which is based on 4 positive signals and 6 negative signals. At the last closing, Kopran Limited’s stock price was INR 258.60. Kopran Limited’s stock price has changed by +0.43% over the past week, +4.48% over the past month and +162.94% over the last year.

No recent analyst target price found for Kopran Limited
No recent average analyst rating found for Kopran Limited

Company Overview Kopran Limited

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspens...Read More

https://www.kopran.com

Parijat House, Mumbai, India, 400018

902

March

INR

India

Adjusted Closing Price for Kopran Limited (KOPRAN:NSE)

Loading...

Unadjusted Closing Price for Kopran Limited (KOPRAN:NSE)

Loading...

Share Trading Volume for Kopran Limited Shares

Loading...

Compare Performance of Kopran Limited Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for KOPRAN:NSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Kopran Limited (Sector: Drug Manufacturers - General )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CIPLA:NSE
Cipla Limited +33.60 (+2.30%) INR1,220.20B 32.83 17.95

ETFs Containing KOPRAN

Symbol Name KOPRAN's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Kopran Limited (KOPRAN:NSE) Stock

Stock Target Advisor's fundamental analysis for Kopran Limited's stock is Slightly Bearish.

KOPRAN:NSE stock's dividend yield is 1.14%. Our analysis grades KOPRAN:NSE stock's dividend yield at C-. This means that KOPRAN:NSE stock's dividend yield is above 70% of the stocks in the Drug Manufacturers - General sector in the NSE exchange. Based on this KOPRAN:NSE may be a average dividend stock for its sector.

Unfortunately we do not have enough data on KOPRAN:NSE's stock to indicate what its average analyst target is.

KOPRAN:NSE stock's Price/Earning ratio is 31.30. Our analysis grades KOPRAN:NSE stock's Price / Earning ratio at A-. This means that KOPRAN:NSE stock's Price/Earning ratio is above 8.999999999999996% of the stocks in the Drug Manufacturers - General sector in the NSE exchange. Based on this KOPRAN:NSE may be undervalued for its sector.

The last closing price of KOPRAN:NSE's stock was INR 258.60.

The most recent market capitalization for KOPRAN:NSE is INR 12.61B.

Unfortunately we do not have enough analyst data on KOPRAN:NSE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Kopran Limited's stock.

As per our most recent records Kopran Limited has 902 Employees.

Kopran Limited's registered address is Parijat House, Mumbai, India, 400018. You can get more information about it from Kopran Limited's website at https://www.kopran.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...